Skip to main content
SpringerLink
Log in

Nutritional supplements and serum lipids: Does anything work?

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Hyperlipidemia is a risk factor for the development of coronary heart disease. Many patients decline prescription lipid-lowering agents and opt instead for supplements. Before any supplement can be routinely recommended it is crucial to examine the types of clinical trials that have been performed, the mechanism by which a supplement is felt to alter lipids, the population studied, potential adverse effects, and the possibility that investigators might be biased. Clinical trial evidence strongly supports the notion that both red yeast rice and plant stanols and sterols effectively lower low-density lipoprotein (LDL) cholesterol. Preliminary evidence supports the possibility that green tea catechins and black tea theaflavins may lower LDL. Data do not support an LDL-lowering claim for guggulipid, policosanol, or cinnamon. Finally, there is strong clinical trial evidence suggesting that marine omega-3 fatty acids lower triglycerides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Williams A: As economy is down, vitamin sales are up. NY Times April 4, 2009.

  2. Heber D, Yip I, Ashley J, et al.: Cholesterol lowering effects of a proprietary Chinese red-yeast rice supplement. Am J Clin Nut 1999, 69:231–236.

    CAS  Google Scholar 

  3. Rippe J, Bonovich K, Colfer H, et al.: A multicenter self-controlled study of Cholestin in subjects with elevated cholesterol (poster presentation (p88)). Presented at the 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Orlando, Florida, USA March 24–27, 1999. Circulation 1999, 99:1123.

    Google Scholar 

  4. Becker DJ, Gordon RY, Morris PB, et al.: Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc 2008, 83:758–764.

    Article  CAS  PubMed  Google Scholar 

  5. Lu Z, Kou W, Du B, et al.: Effect of xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol 2008, 101:1689–1693.

    Article  PubMed  Google Scholar 

  6. Pharmanex: Cholestin. Available at http://www.Pharmanex.com/corp/library/pdf/pip/cholestin.pfd Accessed April 2009.

  7. Heber D, Lembertas A, Lu QY, et al.: Analysis of nine proprietary Chinese red yeast rice dietary supplements: Implications of variability in chemical profile and contents. J Altern Compl Med 2001, 7:133–139.

    Article  CAS  Google Scholar 

  8. Katan MB, Grundy SM, Jones P, et al.: Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965–978.

    Article  CAS  PubMed  Google Scholar 

  9. Food and Drug Administration, Department of Health and Human Services: Food labeling: health claims: plant sterol/stanol esters and coronary heart disease. Fed Register 2000, 65:54685–54739.

    Google Scholar 

  10. Maki KC, Davidson MH, Umporowicz DM, et al.: Lipid responses to plant sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education step 1 diet. Am J Clin Nutr 2001, 74:33–43.

    CAS  PubMed  Google Scholar 

  11. Blair SN, Capuzzi DM, Gottlieb SO, et al.: Incremental reduction of serum total cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 2000, 86:46–52.

    Article  CAS  PubMed  Google Scholar 

  12. Goldberg AC, Ostlund RE, Bateman JH, et al.: Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs. Am J Cardiol 2006, 97:376–379.

    Article  CAS  PubMed  Google Scholar 

  13. Gylling H, Radhakrishnan R, Miettinen TA: Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 1997, 96:4226–4231.

    CAS  PubMed  Google Scholar 

  14. Demonty I, Ras RT, van der Knaap HC, et al.: Continuous dose-response relationship of the LD-cholesterol-lowering effect of phytosterol intake. J. Nutr 2009, 139:271–284.

    CAS  PubMed  Google Scholar 

  15. Plat J, van Onselen EN, van Heugten MM, Mensink RP: Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 2000, 54:671–677.

    Article  CAS  PubMed  Google Scholar 

  16. Richelle M, Enslen M, Hager C, et al.: Both free and esterified plant sterols decrease the bioavailability of betacarotene and alpha-tocopherol, in normocholesterolemic humans. Am J Clin Nutr 2004, 80:171–177.

    CAS  PubMed  Google Scholar 

  17. Noakes M, Clifton P, Ntanios F, et al.: An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 2002, 75:79–86.

    CAS  PubMed  Google Scholar 

  18. Vermeer MA, Mulder TP, Molhuizen HO: Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles. J Agric Food Chem 2008, 56:12031–12036.

    Article  CAS  PubMed  Google Scholar 

  19. Bursill C, Roach PD, Bottema CD, et al.: Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J Agric Food Chem 2001, 49:5639–5645.

    Article  CAS  PubMed  Google Scholar 

  20. Maron DJ, Lu GP, Cai NS, et al.: Cholesterol lowering effect of a theaflavin-enriched green tea extract. Arch Intern Med 2003, 163:1448–1453.

    Article  CAS  PubMed  Google Scholar 

  21. Jujita H, Yamagami T: Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008, 28:450–456.

    Article  Google Scholar 

  22. Japan Atherosclerosis Society: Guidelines for Hyperlipidemia [Japanese]. Tokyo, Japan: Nanzando; 2002.

    Google Scholar 

  23. Nityanand S, Kapoor NK: Cholesterol lowering activity of the various fractions of guggul. Indian J Exp Biol 1973, 11:395–398.

    CAS  PubMed  Google Scholar 

  24. Urizar NL, Liverman AB, Dodds DT, et al.: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002, 296:1703–1706.

    Article  CAS  PubMed  Google Scholar 

  25. Satyavati GV: Gum guggal (Commiphor mukul)—the success story of an ancient insight leading to a modern discovery. Indian J Med Res 1988, 87:327–329.

    CAS  PubMed  Google Scholar 

  26. Singh RB, Niaz MA, Ghosh S: Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994, 8:659–664.

    Article  CAS  PubMed  Google Scholar 

  27. Szapary PO, Wolfe ML, Bloedon LA, et al.: Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 2003, 290:765–772.

    Article  CAS  PubMed  Google Scholar 

  28. Bianchi A, Firenzuoli F, Mazzanti G, et al.: Rhabdomyolysis caused by commiphoroa mukul, a natural lipid lowering agent. Ann Pharmacother 2004, 38:1222–1225.

    Article  PubMed  Google Scholar 

  29. Gouni-Berthold I, Berthold HK: Policosanol: clinical pharmacology and therapeutic significance of a new lipidlowering agent. Am Heart J 2002, 143:356–365.

    Article  CAS  PubMed  Google Scholar 

  30. Berthold HK, Unverdorben S, Degenhardt R, et al.: Effects of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 2006, 295:2262–2269.

    Article  CAS  PubMed  Google Scholar 

  31. Janikula M: Policosanol: a new treatment for cardiovascular disease? Altern Med Rev 2002, 7:203–217.

    PubMed  Google Scholar 

  32. Menendez R, Amor AM, Rodeiro I, et al.: Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res 2001, 32:8–12.

    Article  CAS  PubMed  Google Scholar 

  33. Dulin MF, Hatcher LF, Sasser H, Barringer TA: Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Clin Nutr 2006, 84:1543–1548.

    CAS  Google Scholar 

  34. Cubeddu LX, Cubeddu RJ, Heimowitz T, et al.: Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J 2006, 152:982e1–982e5.

    Article  Google Scholar 

  35. Jarvill-Taylor KJ, Anderson RA, Graves DJ: A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 2001, 20:327–336.

    CAS  PubMed  Google Scholar 

  36. Khan A, Sefad M, Khan MM, et al.: Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003, 26:3215–3218.

    Article  PubMed  Google Scholar 

  37. Mang B, Wolters M, Schmitt B, et al.: Effects of cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006, 36:340–344.

    Article  CAS  PubMed  Google Scholar 

  38. Vanschoonbeek K, Thomassen BJ, Senden JM, et al.: Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetic patients. J Nutr 2006, 136:977–980.

    CAS  PubMed  Google Scholar 

  39. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation 2002, 106:2747–2757.

    Article  PubMed  Google Scholar 

  40. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia [no authors listed]. Med Lett Drugs Ther 2005, 47:91.

  41. Durrington PN, Bhatnagar D, Mackness MI, et al.: An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart 2001, 85:544–548.

    Article  CAS  PubMed  Google Scholar 

  42. Harris WS: N-3 fatty acids and lipoproteins: Comparison of results from human and animal studies. Lipids 1996, 31:243–252.

    Article  CAS  PubMed  Google Scholar 

  43. Chan DC, Watts GF, Mori TA, et al.: Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral adiposity. Am J Clin Nutr 2003, 77:300–307.

    CAS  PubMed  Google Scholar 

  44. Harris WS, Lu G, Rambjor GS, et al.: Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 1997, 66:254–260.

    CAS  PubMed  Google Scholar 

  45. Park Y, Harris WS: Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lip Res 2002, 44:455–463.

    Article  Google Scholar 

  46. DeCaterina R, Bertolotto A, Madonna R, Schmidt EB: N-3 fatty acids in the treatment of diabetic patients. Diabetes Care 2007, 30:1012–1026.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cholesterol Treatment Center, Concord Hospital, 246 Pleasant Street, Suite #210, Concord, NH, 03301, USA

    Mary P. McGowan

Authors
  1. Mary P. McGowan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzanne Proulx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary P. McGowan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGowan, M.P., Proulx, S. Nutritional supplements and serum lipids: Does anything work?. Curr Atheroscler Rep 11, 470–476 (2009). https://doi.org/10.1007/s11883-009-0070-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-009-0070-2

Keywords

Search

Navigation